BioNexus Gene Lab Corporation Stock Other OTC
Equities
BGLC
US0906281086
Healthcare Facilities & Services
Financials (USD)
Sales 2022 | 10.93M | Sales 2023 | 9.77M | Capitalization | 9.36M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | -2M | EV / Sales 2022 | 14.9 x |
Net cash position 2022 | 2.06M | Net cash position 2023 | 5.78M | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
-461
x | P/E ratio 2023 |
-3.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.63% |
Managers | Title | Age | Since |
---|---|---|---|
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Keong Yap
BRD | Director/Board Member | 68 | 22-03-06 |
Wei Foong Lim
BRD | Director/Board Member | 48 | Dec. 10 |
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
1st Jan change | Capi. | |
---|---|---|
-16.65% | 8.34B | |
+39.98% | 3.59B | |
-32.00% | 2.75B | |
-7.71% | 2.48B | |
-9.56% | 2.32B | |
-13.29% | 1.79B | |
-19.46% | 1.54B | |
-40.57% | 1.21B | |
+9.70% | 1.13B |